Target intelligence / Profile preview

Ribosomal protein S23 pseudogene 7 (RPS23P7)

Target
RPS23P7
Molecular classification
Other, pseudogene, derived from ribosomal structural protein gene family
01

Overview

Ribosomal protein S23 pseudogene 7 (RPS23P7) is a processed pseudogene derived from the ribosomal protein S23 (RPS23) gene. Like other pseudogenes, it is the result of retrotransposition events and does not encode a functional protein[1][3][5]. The parent gene, RPS23, encodes a component of the 40S subunit of the ribosome that is essential for protein biosynthesis[3][5]. However, RPS23P7 does not have a known cellular function, is not translated, and is not implicated in any therapeutic or diagnostic context. Pseudogenes like RPS23P7 are generally regarded as non-functional genomic elements, though in rare cases, pseudogenes can exert regulatory effects—there is no such evidence for RPS23P7 at this time[1][3][5]. For reference, the functional parent gene (RPS23) is categorized as a structural ribosomal protein and is not a direct drug target, but disruptions in its functional expression can have disease associations[1][3]. RPS23P7, being a pseudogene copy, plays no known biological or pathological role. Note: If you are seeking information about a therapeutically relevant target, refer to the functional ribosomal protein S23 (RPS23) rather than its pseudogenes.

Other names
RPS23P7processed pseudogene 7 of ribosomal protein S23RPS23 pseudogene 7

Beyond the preview

Go deeper on Ribosomal protein S23 pseudogene 7 (RPS23P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S23 pseudogene 7 (RPS23P7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call